Studying Patient Experiences in Osteoporosis Clinical Trials
- Disease/Condition
- Osteoporosis
- Study type
- Observational
- Primary sponsor
- Power Life Sciences Inc.
- Location
- San Francisco, United States of America
- Phase
- N/A
- Start date
- Jul 01, 2024
- End date
- Jul 01, 2026
- Enrollment
- 500 participants
Number of patients who decide to join in an osteoporosis clinical trial,Rate of patients who remain in osteoporosis clinical trial to trial completion
Clinical trials for osteoporosis are designed to assess the safety and effectiveness of novel
 osteoporosis treatments. These trials play a crucial role in establishing whether these new
 treatments outperform existing options and provide substantial evidence to support their
 adoption within the wider population.
 
 The primary aim of this particular study is to investigate the experiences of individuals
 diagnosed with osteoporosis who participate in a distinct clinical trial involving a medical
 intervention. The focus will be on closely monitoring the rates of trial completion and
 withdrawal among these participants.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05937945
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05937945 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Osteoporosis. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.